Real-time enrollment status for this metastatic castration resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 4:50 AM UTC
| NCT Number | NCT07824349 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration Resistant Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 210 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Juri Biosciences, Inc. |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 14, 2026: Clinical trial NCT07824349 is currently recruiting participants. This phase1 study for metastatic castration resistant prostate cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Juri Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07824349 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07824349 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.